August 3rd,2020, Shanghai Lionrun SARS-CoV-2 diagnostics pipelines welcome 2 new members: SARS-CoV-2 Rapid Antigen test kit, and SARS-CoV-2 Rapid Nucleic Acid test kit. Both products have gained European Union CE certification, as we continue to provide the global fight against the COVID-19 accurate and efficient diagnostics tools.
SARS-CoV-2 Rapid Antigen test kit employs Immunochromatography (GICA) methods, applicable for detecting SARS-CoV-2 virus Antigen N protein from human nose swabs, throat swabs, and sinus swabs. It overcomes the antigen testing kits main weaknesses, that being unable to differentiate past or present infections; further aiding front-line healthcare workers to quickly make clinical decisions.
SARS-CoV-2 Rapid Nucleic Acid test kit applies RT-RAA (Recombinase Aided Amplification) technology and LFD (Lateral Flow Dipstick) technology to achieve rapid and accurate detection of SARS-CoV-2. It uses only lateral flow dipstick to detect nucleic acids without using large PCR equipment, while giving us results easily identifiable by naked eye, faster, and just as sensitive as PCR tests. Currently this product is undergoing clinical trial in Chongqing public health centers, and in different clinical settings, different onset times, different disease stages yielded 100% positive results, while matching the results from RT-qPCR testing at 100%.
Currently Shanghai Lionrun has a total of 3 different SARS-CoV-2 related test kits earing European Union green light to enter the EU market, becoming a world leader in SARS-CoV-2 test kits makers.
We fight for the global battle against the pandemic!